US HB5030 | 2021-2022 | 117th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 51-4)
Status: Introduced on August 13 2021 - 25% progression, died in committee
Action: 2021-08-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on August 13 2021 - 25% progression, died in committee
Action: 2021-08-13 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To improve diversity in clinical trials and data collection for COVID-19 and future public health threats to address social determinants of health.
Title
DIVERSE Trials Act Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act
Sponsors
History
Date | Chamber | Action |
---|---|---|
2021-08-13 | House | Referred to the Subcommittee on Health. |
2021-08-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2021-08-13 | House | Introduced in House |
Same As/Similar To
SB2706 (Same As) 2021-08-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB4486 (Related) 2022-06-23 - Read twice and referred to the Committee on Finance.
SB4486 (Related) 2022-06-23 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/5030/all-info |
Text | https://www.congress.gov/117/bills/hr5030/BILLS-117hr5030ih.pdf |